HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler
Collaboration Expands Clinical Sites for Trial […]
Collaboration Expands Clinical Sites for Trial […]
In two separate rulings on Tuesday, federal judges temporarily halted the Biden Administration’s COVID-19 vaccine mandates for healthcare workers and federal contractors. One ruling, in a Missouri federal district court, prohibits CMS from enforcing its COVID-19 vaccine mandate in Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming. A second […]
NATIONAL INSTITUTE OF HEALTH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS […]
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry […]
IONIQ Sciences Proudly Announces that Mrs. Jan Poulsen is a Lung Cancer Hero […]
None of the mutations in the Omicron variant interfere with any of the Company’s COVID-19 PCR diagnostic assays […]
The CAO Group, Inc. has launched the world’s first in-office and take-home teeth whitening strip system for dental practices, SheerWhite® In-Office Teeth Whitening Strips and SheerWhite® Take Home Teeth Whitening Strips. […]
IONIQ Sciences Announces MedTech Breakthrough Award for “Oncology Innovation of the Year 2021” […]
Bluewind Medical announced the successful completion of patient enrollment in the OASIS pivotal clinical study that will be the basis by which the company will seek US-FDA (Food & Drug Administration) marketing clearance in the United States. OASIS is a 150-patient prospective clinical study designed to demonstrate the safety and efficacy of Bluewind Medical’s RENOVA […]
BioUtah and BioHive on Nov. 12 presented with great fanfare the Renalytix BioHive Summit – the 12th annual gathering of Utah’s life sciences community – but this year with a new name. Convening under the BioHive banner is part of a larger effort to brand, build and bring together Utah’s fast-growing life sciences hub. We […]
Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.) on Tuesday, November 16, introduced the CURES 2.0 bill, a sequel to the initial 21st Century Cures Act that passed Congress in 2015. According to a statement released by DeGette, while the first CURES bill sought to improve how new drugs and treatments are researched and developed in […]
Statement from Senator Orrin G. Hatch: Drug Pricing Provisions in Infrastructure Bill Could Undermine Hatch-Waxman […]